Non-CNS patient outcomes treated via the NHS proton overseas programme

被引：0
|
作者：
Hwang, E. J. [1 ,2 ]
Gaito, S. [3 ]
France, A. [3 ]
Thwaites, D. [2 ,4 ]
Ahern, V. [5 ,6 ]
Indelicato, D. [7 ]
Smith, E. [1 ,3 ,8 ]
机构：
[1] Christie NHS Fdn Trust, Proton Beam Therapy, Manchester, Lancs, England
[2] Univ Sydney, Med Phys, Sydney, NSW, Australia
[3] Christie NHS Fdn Trust, Proton Clin Outcomes Unit, Manchester, Lancs, England
[4] Univ Leeds, Med Phys, Leeds, W Yorkshire, England
[5] Crown Princess Mary Canc Ctr, Radiat Oncol, Westmead, NSW, Australia
[6] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia
[7] Univ Florida, Radiat Oncol, Jacksonville, FL USA
[8] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO-0063
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group
    Gaito, S.
    Hwang, E. J.
    France, A.
    Aznar, M. C.
    Burnet, N.
    Crellin, A.
    Holtzman, A. L.
    Indelicato, D. J.
    Timmerman, B.
    Whitfield, G. A.
    Smith, E.
    CLINICAL ONCOLOGY, 2023, 35 (05) : 283 - 291
  • [2] Imaging aspects of neurologic emergencies in children treated for non-CNS malignancies
    Kaste, SC
    Rodriguez-Galindo, C
    Furman, WL
    Langston, J
    Thompson, SJ
    PEDIATRIC RADIOLOGY, 2000, 30 (08) : 558 - 565
  • [3] Imaging aspects of neurologic emergencies in children treated for non-CNS malignancies
    S. C. Kaste
    Carlos Rodriguez-Galindo
    Wayne L. Furman
    James Langston
    Stephen J. Thompson
    Pediatric Radiology, 2000, 30 : 558 - 565
  • [4] Late Toxicity Outcomes of the NHS Proton Overseas Program Since 2008
    Hwang, E. J.
    Gaito, S.
    France, A. K.
    Crellin, A.
    Thwaites, D.
    Ahern, V.
    Indelicato, D. J.
    Smith, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E347 - E347
  • [5] Rapid proton fat-water spectroscopy for the characterization of non-CNS lesions in vivo
    Riedy, G
    CLINICAL IMAGING, 2003, 27 (03) : 145 - 149
  • [6] Proton Beam Therapy for Central Nervous System tumours: outcomes from the Proton Overseas Programme
    Gaito, S.
    Hwang, E.
    France, A.
    Whitfield, G.
    Pan, S.
    Price, G.
    Aznar, M.
    Crellin, A.
    Indelicato, D.
    Smith, E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S771 - S773
  • [7] SERVICE EVALUATION OF EARLY OUTCOMES AND TOXICITY FOR PAEDIATRIC INTRACRANIAL EPENDYMOMAS TREATED WITHIN THE UK PROTON BEAM THERAPY OVERSEAS PROGRAMME
    Gains, Jenny
    Indelicato, Daniel
    Chang, Andrew
    Confer, Michael
    Thorp, Nicola
    Chang, Yen-Ching
    Smith, Ed
    Hackshaw, Allan
    Crellin, Adrian
    NEURO-ONCOLOGY, 2016, 18 : 38 - 38
  • [8] POSTNATAL ALTERATION OF NON-CNS PHYSIOLOGY EVALUATED IN RATS TREATED WITH TERATOGENS DURING THE FETAL PERIOD
    CHRISTIAN, MS
    JOHNSON, EM
    TERATOLOGY, 1979, 19 (02) : A23 - A23
  • [9] Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status
    Drilon, A.
    Shen, L.
    van Tilburg, C. M.
    Tan, D. S. W.
    Kummar, S.
    Lin, J. J.
    Doz, F.
    McDermott, R.
    Albert, C. M.
    Berlin, J.
    Bielack, S.
    Lassen, U. N.
    Tahara, M.
    Norenberg, R.
    Fellous, M.
    Nogai, H.
    Xu, R.
    Laetsch, T. W.
    Hong, D. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S599 - S599
  • [10] Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
    Bauer, Todd M.
    Shaw, Alice T.
    Johnson, Melissa L.
    Navarro, Alejandro
    Gainor, Justin F.
    Thurm, Holger
    Pithavala, Yazdi K.
    Abbattista, Antonello
    Peltz, Gerson
    Felip, Enriqueta
    TARGETED ONCOLOGY, 2020, 15 (01) : 55 - 65
12345